🇺🇸 FDA
Patent

US 9931389

Genetic attenuation of plasmodium by B9 gene disruption

granted A61KA61K2039/522A61K2039/545

Quick answer

US patent 9931389 (Genetic attenuation of plasmodium by B9 gene disruption) held by Sanaria Inc. expires Mon Mar 29 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Sanaria Inc.
Grant date
Tue Apr 03 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 29 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K2039/522, A61K2039/545, A61K39/015